Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2019, Article ID 4762937, 6 pages
https://doi.org/10.1155/2019/4762937
Case Series

Anti-N-Methyl-D-Aspartate Encephalitis as Paraneoplastic Manifestation of Germ-Cells Tumours: A Cases Report and Literature Review

1Department of Immunology. Hospital Universitario Ramón y Cajal, Ctra. Colmenar Km 9,1, 28034 Madrid, Spain
2Department of Neurology. Hospital Universitario Ramón y Cajal, Ctra. Colmenar Km 9,1, 28034 Madrid, Spain

Correspondence should be addressed to Claudia Geraldine Rita; moc.liamg@gatiraidualc

Received 24 November 2018; Revised 18 February 2019; Accepted 19 February 2019; Published 10 March 2019

Academic Editor: Christian Drouet

Copyright © 2019 Claudia Geraldine Rita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Dalmau and F. Graus, “Antibody-mediated encephalitis,” The New England Journal of Medicine, vol. 378, no. 9, pp. 840–851, 2018. View at Publisher · View at Google Scholar · View at Scopus
  2. Á. Carrasco, I. Alarcón, C. González, and F. Graus, “Identificación y utilidad clínica de los anticuerpos antineuronales,” Inmunología, vol. 33, no. 4, pp. 128–136, 2014. View at Publisher · View at Google Scholar
  3. M. Guasp and J. Dalmau, “Encefalitis por anticuerpos contra el receptor de NMDA,” Medicina Clínica, vol. 151, no. 2, pp. 71–79, 2018. View at Publisher · View at Google Scholar
  4. F. Graus, M. J. Titulaer, and R. Balu, “A clinical approach to diagnosis of autoimmune encephalitis,” The Lancet Neurology, vol. 15, no. 4, pp. 391–404, 2016. View at Publisher · View at Google Scholar
  5. J. Dalmau, E. Tüzün, H.-Y. Wu et al., “Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma,” Annals of Neurology, vol. 61, no. 1, pp. 25–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. G. Hughes, X. Peng, A. J. Gleichman et al., “Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis,” The Journal of Neuroscience, vol. 30, no. 17, pp. 5866–5875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Dalmau, A. J. Gleichman, and E. G. Hughes, “Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies,” The Lancet Neurology, vol. 7, no. 12, pp. 1091–1098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Titulaer, L. McCracken, I. Gabilondo et al., “Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study,” The Lancet Neurology, vol. 12, no. 2, pp. 157–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Gresa-Arribas, M. J. Titulaer, A. Torrents et al., “Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study,” The Lancet Neurology, vol. 13, no. 2, pp. 167–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kaneko, J. Kaneko, N. Tominaga et al., “Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis,” Journal of Neurology, vol. 265, no. 3, pp. 586–596, 2018. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Salehi, A. K. Yuan, G. Stevens, R. Koshy, and W. F. Klein, “A case of severe anti-N-methyl D-aspartate (Anti-NMDA) receptor encephalitis with refractory autonomic instability and elevated intracranial pressure,” American Journal of Case Reports, vol. 19, pp. 1216–1221, 2018. View at Publisher · View at Google Scholar · View at Scopus
  12. S. R. Irani and A. Vincent, “NMDA receptor antibody encephalitis,” Current Neurology and Neuroscience Reports, vol. 11, no. 3, pp. 298–304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. J. Sinclair, L. Wienholt, E. Tantsis, F. Brilot, and R. C. Dale, “Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology,” Developmental Medicine & Child Neurology, vol. 55, no. 1, pp. 71–75, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Vincent, C. G. Bien, S. R. Irani, and P. Waters, “Autoantibodies associated with diseases of the CNS: new developments and future challenges,” The Lancet Neurology, vol. 10, no. 8, pp. 759–772, 2011. View at Publisher · View at Google Scholar
  15. J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M. R. Rosenfeld, and R. Balice-Gordon, “Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis,” The Lancet Neurology, vol. 10, no. 1, pp. 63–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Martin, E. Jolliffe, and S. P. Hertweck, “Ovarian teratoma associated with coexisting Anti-N-Methyl-D-Aspartate receptor and glial fibrillary acidic protein autoimmune meningoencephalitis in an adolescent girl: a case report,” Journal of Pediatric & Adolescent Gynecology, vol. 31, no. 3, pp. 321–324, 2018. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Cundiff, N. Elawabdeh, M. M. Naguib et al., “Does MAP2 have a role in predicting the development of anti-NMDAR encephalitis associated with benign ovarian teratoma? A report of six new pediatric cases,” Pediatric and Developmental Pathology, vol. 18, no. 2, pp. 122–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Bost, E. Chanson, G. Picard et al., “Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies,” Journal of Neurology, vol. 265, no. 10, pp. 2190–2200, 2018. View at Publisher · View at Google Scholar · View at Scopus
  19. K. W. Lee and L. M. Liou, “Fulminant course in a patient with anti-N-methyl-D-aspartate receptor encephalitis with bilateral ovarian teratomas: a case report and literature review,” Medicine (Baltimore), vol. 97, no. 15, p. e0339, 2018. View at Publisher · View at Google Scholar